BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27922551)

  • 1. Sphingosine-1-Phosphate: A Potential Biomarker and Therapeutic Target for Endothelial Dysfunction and Sepsis?
    Winkler MS; Nierhaus A; Poppe A; Greiwe G; Gräler MH; Daum G
    Shock; 2017 Jun; 47(6):666-672. PubMed ID: 27922551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis.
    Hemdan NY; Weigel C; Reimann CM; Gräler MH
    Eur J Immunol; 2016 Dec; 46(12):2767-2777. PubMed ID: 27683081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge.
    Stepanovska B; Lange AI; Schwalm S; Pfeilschifter J; Coldewey SM; Huwiler A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S1P control of endothelial integrity.
    Xiong Y; Hla T
    Curr Top Microbiol Immunol; 2014; 378():85-105. PubMed ID: 24728594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum concentrations of sphingosine-1-phosphate in sepsis.
    Winkler MS; Nierhaus A; Holzmann M; Mudersbach E; Bauer A; Robbe L; Zahrte C; Geffken M; Peine S; Schwedhelm E; Daum G; Kluge S; Zoellner C
    Crit Care; 2015 Oct; 19():372. PubMed ID: 26498205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
    Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B
    J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Conditions Disrupt Constitutive Endothelial Cell Barrier Stabilization by Alleviating Autonomous Secretion of Sphingosine 1-Phosphate.
    Jeya Paul J; Weigel C; Müller T; Heller R; Spiegel S; Gräler MH
    Cells; 2020 Apr; 9(4):. PubMed ID: 32290092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell barrier regulation by sphingosine 1-phosphate.
    McVerry BJ; Garcia JG
    J Cell Biochem; 2004 Aug; 92(6):1075-85. PubMed ID: 15258893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-phosphate promotes barrier-stabilizing effects in human microvascular endothelial cells via AMPK-dependent mechanisms.
    Dennhardt S; Finke KR; Huwiler A; Coldewey SM
    Biochim Biophys Acta Mol Basis Dis; 2019 Apr; 1865(4):774-781. PubMed ID: 30660683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate has dual functions in the regulation of endothelial cell permeability and Ca2+ metabolism.
    Itagaki K; Yun JK; Hengst JA; Yatani A; Hauser CJ; Spolarics Z; Deitch EA
    J Pharmacol Exp Ther; 2007 Oct; 323(1):186-91. PubMed ID: 17626797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of FAK in S1P-regulated endothelial permeability.
    Belvitch P; Dudek SM
    Microvasc Res; 2012 Jan; 83(1):22-30. PubMed ID: 21925517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate and inflammation.
    Obinata H; Hla T
    Int Immunol; 2019 Aug; 31(9):617-625. PubMed ID: 31049553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate as a link between blood coagulation and inflammation.
    Rauch BH
    Cell Physiol Biochem; 2014; 34(1):185-96. PubMed ID: 24977491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular permeability by sphingosine 1-phosphate.
    Wang L; Dudek SM
    Microvasc Res; 2009 Jan; 77(1):39-45. PubMed ID: 18973762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrier maintenance by S1P during inflammation and sepsis.
    Ziegler AC; Gräler MH
    Tissue Barriers; 2021 Oct; 9(4):1940069. PubMed ID: 34152926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
    Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells.
    Qiu Y; Shen J; Jiang W; Yang Y; Liu X; Zeng Y
    Histol Histopathol; 2022 Mar; 37(3):213-225. PubMed ID: 35118637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
    Spampinato SF; Obermeier B; Cotleur A; Love A; Takeshita Y; Sano Y; Kanda T; Ransohoff RM
    PLoS One; 2015; 10(7):e0133392. PubMed ID: 26197437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption.
    Vutukuri R; Brunkhorst R; Kestner RI; Hansen L; Bouzas NF; Pfeilschifter J; Devraj K; Pfeilschifter W
    J Neurochem; 2018 Jan; 144(2):172-185. PubMed ID: 29023711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential.
    Aoki M; Aoki H; Ramanathan R; Hait NC; Takabe K
    Mediators Inflamm; 2016; 2016():8606878. PubMed ID: 26966342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.